Middle East & Africa Molecular Diagnostics Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

No. of Pages: 120
Report Code: TIPRE00026716
Category: Life Sciences
Middle East & Africa Molecular Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Molecular Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Molecular Diagnostics Market Regional Analysis

6.2 Middle East & Africa Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Molecular Diagnostics Market Forecast Analysis

7. Middle East & Africa Molecular Diagnostics Market Analysis – by Disease Area

7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Oncology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Infectious Disease
  • 7.2.1 Overview
  • 7.2.2 Infectious Disease: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Genetic Testing
  • 7.3.1 Overview
  • 7.3.2 Genetic Testing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Cardiac Diseases
  • 7.4.1 Overview
  • 7.4.2 Cardiac Diseases: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Immune System Disorders
  • 7.5.1 Overview
  • 7.5.2 Immune System Disorders: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Middle East & Africa Molecular Diagnostics Market Analysis – by Technology

8.1 Polymerase Chain Reaction
  • 8.1.1 Overview
  • 8.1.2 Polymerase Chain Reaction: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
  • 8.2.1 Overview
  • 8.2.2 Isothermal Nucleic Acid Amplification Technology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 DNA Sequencing & Next-Generation Sequencing
  • 8.3.1 Overview
  • 8.3.2 DNA Sequencing & Next-Generation Sequencing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 DNA Microarrays
  • 8.4.1 Overview
  • 8.4.2 DNA Microarrays: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 In-Situ Hybridization
  • 8.5.1 Overview
  • 8.5.2 In-Situ Hybridization: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Middle East & Africa Molecular Diagnostics Market Analysis – by Product and Services

9.1 Assays & Kits
  • 9.1.1 Overview
  • 9.1.2 Assays & Kits: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Instruments
  • 9.2.1 Overview
  • 9.2.2 Instruments: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Services & Software
  • 9.3.1 Overview
  • 9.3.2 Services & Software: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Middle East & Africa Molecular Diagnostics Market Analysis – by End User

10.1 Hospitals & Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals & Clinics: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Diagnostic Laboratories
  • 10.2.1 Overview
  • 10.2.2 Diagnostic Laboratories: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Research & Academic Institutes
  • 10.3.1 Overview
  • 10.3.2 Research & Academic Institutes: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Middle East & Africa Molecular Diagnostics Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa
  • 11.2.1 Middle East & Africa Molecular Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 11.2.1.1 Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 South Africa: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.1.1 South Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Disease Area
    • 11.2.1.1.2 South Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.1.3 South Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Product and Services
    • 11.2.1.1.4 South Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by End User
  • 11.2.1.2 Saudi Arabia: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.2.1 Saudi Arabia: Middle East & Africa Molecular Diagnostics Market Breakdown, by Disease Area
    • 11.2.1.2.2 Saudi Arabia: Middle East & Africa Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.2.3 Saudi Arabia: Middle East & Africa Molecular Diagnostics Market Breakdown, by Product and Services
    • 11.2.1.2.4 Saudi Arabia: Middle East & Africa Molecular Diagnostics Market Breakdown, by End User
  • 11.2.1.3 UAE: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.3.1 UAE: Middle East & Africa Molecular Diagnostics Market Breakdown, by Disease Area
    • 11.2.1.3.2 UAE: Middle East & Africa Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.3.3 UAE: Middle East & Africa Molecular Diagnostics Market Breakdown, by Product and Services
    • 11.2.1.3.4 UAE: Middle East & Africa Molecular Diagnostics Market Breakdown, by End User
  • 11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Disease Area
    • 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by Product and Services
    • 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 bioMerieux SA
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Danaher
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Illumina Inc
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Novartis AG
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Qiagen NV
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Siemens Healthineers AG
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Thermo Fisher Scientific Inc
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Middle East & Africa Molecular Diagnostics Market

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Novartis AG
  • Qiagen NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)